This is an exciting time for Alzheimer’s clinical trials, with leaps and bounds of progress in the development of new-generation treatments over the last few years. Due to ongoing research and active clinical trials for Alzheimer’s, we are closer than ever to finding new, effective treatments to diagnose the disease, treat symptoms, stop progression and eventually provide a cure.
Success has been reported recently with new generation medications Lecanemab and Donanemab, both of which have been demonstrated, in phase 3 international clinical trials, to slow progression of Alzheimer’s disease and its symptoms. Both of which are ran within Re:Cognition Health clinics.
Participating in Clinical Trials
“Taking part in clinical research gives us hope. The breakthrough may be just around the corner, and we are at the front of the queue,” one clinical trials volunteer explained.
By participating in Alzheimer’s clinical trials, volunteers help advance medical knowledge regarding the safety and efficacy of new treatments, drugs, devices and interventions. This information enables researchers to better understand how diseases develop, progress and respond to treatment.
Clinical trials also give volunteers access to cutting-edge treatments not available on the market. This can be particularly valuable for those who have exhausted treatment options or for those for whom treatment is not available, such as those with Alzheimer’s disease.
Benefits of Alzheimer’s Clinical Trials
- Accurate diagnosis with the most advanced diagnostic tools or biomarkers
- The chance for disease modification to SLOW/STOP progression
- Opportunities to get early access to new generation drugs that will not be available on the market for 4-5 years
- Patients can still take all of their normal medications even those prescribed for memory loss (as these work on symptoms and not the build up of plaques in the brain).
- The chance to proactively taking control of your health and future
- Regular health monitoring with continuity of care by an expert medical team
- Outstanding medical care provided at no cost, including comprehensive health screens, MRI scans and PET scans
- Free to participate with expenses reimbursed
- The knowledge that volunteers are contributing to vital research and helping to develop medications for future generations
- The chance to withdraw at any stage – patients are free to leave if they ever wish to and there will never be any financial penalty or commitment.
Clinical Trial Opportunities through Re:Cognition Health
Re:Cognition Health is actively enrolling participants aged 55 and over for Mild Cognitive Impairment and Alzheimer’s clinical trials. There are also many ongoing Alzheimer’s clinical trials, as well as upcoming trial opportunities for healthy volunteers who may be worried about or have a known increased risk of developing Alzheimer’s disease. Studies are also available for individuals with Parkinson’s Disease, Multiple sclerosis, migraine and Long Covid.
Of course, with any disease, an early diagnosis is essential to access to new-generation medications. It’s important to be aware of the early symptoms and consult with a medical expert at the earliest opportunity. We will liaise with your primary healthcare physician, neurologist, or memory clinic at every step of the way with you.
You can learn more about our clinical trials at www.recognitionhealthusa.com/memory-studies.